ScinoPharm Taiwan Ltd 2014 SR
The report highlights ScinoPharm's commitment to sustainable management in the pharmaceutical industry during 2014. Key achievements include ranking in the top 5% of the TWSE Corporate Governance Evaluation and being listed among the 'CSR 100 Companies' by CommonWealth Magazine. The company successfully transitioned from oil-fired to gas boilers, significantly reducing CO2 emissions. Social initiatives included the 'ScinoPharm Art' lectures and community outreach programs like plant donations. Despite financial challenges due to market competition, the company maintained high standards in R&D and environmental protection, achieving a 68% annual water-recycling rate.
Company: ScinoPharm Taiwan Ltd
Sector: Manufacturing
Country: Taiwan
Year: 2014
Type: SR
Pages: 32
ScinoPharm Taiwan Ltd
The report highlights ScinoPharm's commitment to sustainable management in the pharmaceutical industry during 2014. Key achievements include ranking in the top 5% of the TWSE Corporate Governance Evaluation and being listed among the 'CSR 100 Companies' by CommonWealth Magazine. The company successfully transitioned from oil-fired to gas boilers, significantly reducing CO2 emissions. Social initiatives included the 'ScinoPharm Art' lectures and community outreach programs like plant donations. Despite financial challenges due to market competition, the company maintained high standards in R&D and environmental protection, achieving a 68% annual water-recycling rate.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Published
Oct 1, 2015
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees